Serina Therapeutics Inc (SER) — Cash Flow Quality Index
Serina Therapeutics Inc (SER) has a Cash Flow Quality Index of -2.14x as of September 2024. Operating cash flow of $-2.96 Million is below net income of $1.38 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Serina Therapeutics Inc assets under control for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Serina Therapeutics Inc Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Serina Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Serina Therapeutics Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Serina Therapeutics Inc (2023–2023)
Year-by-year earnings quality comparison for Serina Therapeutics Inc. For live market cap and the full company financial profile, see how much is Serina Therapeutics Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.47x | $-2.48 Million | $5.27 Million | — |